23 March 2022 - U.S. Senate Majority Leader Chuck Schumer said on Tuesday he intends to hold votes this spring on a bill that would cap the cost of insulin, a life-sustaining diabetes drug.
The legislation would place a $35 monthly cap on what patients pay for insulin, Schumer said, and would be paired with another emerging bipartisan plan to drive down the price "in a more comprehensive way, including having the uninsured protected," Schumer told reporters.